Oklahoma's state regulator may be about to crack down on THC-infused slushies, despite their growing popularity with consumers.
Cannabis enthusiasts in Oklahoma looking to cool off this summer with a THC-infused slushy received bad news this week, after the state's regulatory declared that the products are, "unlikely to meet requirements set forth in Oklahoma statutes and rules."
Over the last year THC slushy machines have become an increasingly common fixture of Oklahoma cannabis dispensaries—coming in flavours such as blue raspberry and watermelon—while typically retailing for approximately USD $12-15.
In this instance, the finished product is the slushy mixture to be dispensed to patients/caregivers, not the syrup. If water, ice, or any other substance is added to the product, additional testing is required to ensure the product is safe for consumption and final-product labelling is accurate. Oklahoma Medical Marijuana Authority (OMMA)
However, while their popularity is growing amongst medicinal marijuana patients, the Oklahoma Medical Marijuana Authority (OMMA) now claim that they are in violation of a number of state regulations.
These include the legal requirement to provide product packaging that is child resistant, while individual dispensaries are not "allowed to alter, package, or label products."
The update was issued by the organisation after its offices began receiving, "multiple inquiries regarding the processing and dispensing of marijuana-infused slushies on-site at medical marijuana dispensaries", although it has declined to confirm whether it has plans to enforce the law.
As a result, the OMMA was forced to publish a memo addressing the subject, where it argued that cannabis-infused slushies are unlikely to meet the legal requirements stipulated by the state's various regulatory bodies, including:
- All products must be in child-resistant packages. Generally, this means the package must be difficult for a 5-year-old to open; opaque; and, if intended for multiple uses (for example, containing multiple servings), capable of being resealed while remaining child-resistant.
- The medical marijuana production batch that must be tested is the finished product. In this instance, the finished product is the slushy mixture to be dispensed to patients/caregivers, not the syrup. If water, ice, or any other substance is added to the product, additional testing is required to ensure the product is safe for consumption and final-product labelling is accurate.
- Dispensaries are not allowed to alter, package, or label products. In addition, dispensaries must refuse to accept or return any medical marijuana products that have not been properly tested, packaged, and labelled by a licensed processor.
Nonetheless, several business owners have indicated they are confused by the OMMA's new stance on THC-infused slushies, such as the owner of the Fighting Flower cannabis dispensary, Drew Todhunter.
According to Todhunter, he purchased the THC slushy machine from a licensed company known as Glazee several months ago. Each $15 slushy comes premade and is dispensed directly into a childproof cup, with health information clearly labelled on the product packaging.
"They're completely compliant under my understanding of the law," Todhunter said.
"Everything has been going out in compliant packaging. So, if it leaves the store in a compliant package, then I personally don't see an issue with it."
This pot stock could reach new heights in 2020 due to Coronavirus
The COVID-19 pandemic is showing no signs of slowing down, and as global markets enter meltdown many cannabis companies are feeling the effects of capital crunch.
While the market crash will continue for some time, it represents a golden opportunity for investors who are capable of riding out the volatility until share prices rally.
Luckily, one pot stock has developed antimicrobial drug that can already treat two superbugs while limiting their ability to develop antibiotic resistance.
Investors can also start picking up shares at rock bottom prices, as global investor sentiment continues to dampen thanks to COVID-19.
& Keep Up to Date
Get the latest pot stock recommendations, cannabis news
and industry updates straight to your inbox!